Skip to main content

Table 1 Baseline demographic and clinical characteristics

From: Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder

Patient characteristics a

N (%) or mean (±SD) b

SCORPIO (n = 1906)

ARIES (n = 1270)

CAPRICORN (n = 1251)

Pooled trials (n = 4427)

Age

59.1 (±12.4)

60.2 (±13.4)

59.1 (±13.0)

59.4 (±12.9)

Female

1372 (72.0%)

950 (74.8%)

857 (68.5%)

3179 (71.8%)

BMI

27.8 (±4.9)

30.2 (±7.0)

29.4 (±6.4)

28.9 (±6.1)

Geographical region

Western Europe

1906 (54.2%)

0 (0.0%)

359 (28.7%)

1392 (31.4%)

Eastern Europe

873 (45.8%)

0 (0.0%)

222 (17.8%)

1095 (24.7%)

USA

0 (0.0%)

127 (10.0%)

584 (46.7%)

1727 (39.0%)

Canada

0 (0.0%)

1143 (90.0%)

86 (6.9%)

213 (4.8%)

Previously treated with antimuscarinics

946 (49.6%)

714 (56.2%)

642 (51.3%)

2302 (52.0%)

Baseline mean number of micturitions per 24 h

11.6 (±2.9)

11.7 (±3.4)

11.6 (±3.1)

11.6 (±3.1)

Baseline mean number of incontinence episodes per 24 h

1.7 (±2.4)

2.1 (±2.7)

2.3 (±2.3)

1.8 (±2.5)

  1. aBMI: Body mass index; USA: United States of America.
  2. bSD: Standard deviation.